Skip to main content
. 2022 Feb 4;14(2):359. doi: 10.3390/pharmaceutics14020359

Table 4.

Microparticles from PLGA-PEG copolymers for controlled drug delivery.

Particles Drug Treatment Reference
PLGA-PEG-PLGA -montmorillonite MPs Aspirin Inflammations, fever and pain reduction [96]
PLGA-PEG MPs Neuregulin (NRG) Myocardial infarction [117]
PLGA-PEG-PLGA MPs Bone morphogenetic protein 2 (BMP-2) Bone regeneration [118]
PLGA-PEG Clonidine Arterial pressure [97]
PLGA-PEG Lysozyme Tissue engineering [119]
PLGA-PEG-PLGA MPs Insulin Diabetes [91]